Fmr LLC Purchases 449,854 Shares of Balchem Co. (NASDAQ:BCPC)

FMR LLC grew its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 944.3% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 497,495 shares of the basic materials company's stock after acquiring an additional 449,854 shares during the quarter. FMR LLC owned about 1.53% of Balchem worth $87,559,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of BCPC. William Blair Investment Management LLC raised its position in Balchem by 8.4% in the second quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company's stock valued at $35,998,000 after purchasing an additional 18,104 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Balchem by 22.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company's stock valued at $3,169,000 after acquiring an additional 3,732 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company's stock valued at $63,707,000 after acquiring an additional 7,562 shares during the period. Fiera Capital Corp bought a new position in shares of Balchem in the third quarter valued at approximately $4,201,000. Finally, Envestnet Asset Management Inc. lifted its holdings in shares of Balchem by 9.9% in the second quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company's stock valued at $17,589,000 after purchasing an additional 10,285 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Up 0.7 %

Shares of NASDAQ:BCPC traded up $1.15 during trading on Friday, hitting $177.53. The stock had a trading volume of 64,233 shares, compared to its average volume of 109,791. Balchem Co. has a 12 month low of $131.10 and a 12 month high of $186.03. The company has a market capitalization of $5.77 billion, a PE ratio of 47.72, a PEG ratio of 5.32 and a beta of 0.67. The firm's fifty day moving average is $174.75 and its 200 day moving average is $168.07. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Analysts Set New Price Targets

BCPC has been the topic of a number of recent analyst reports. HC Wainwright lifted their price target on Balchem from $185.00 to $190.00 and gave the stock a "buy" rating in a report on Monday, November 4th. StockNews.com raised Balchem from a "hold" rating to a "buy" rating in a research note on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.